Follow
Dr Shunsheng Zheng
Dr Shunsheng Zheng
B&D Director, Celleron Therapeutics
Verified email at cellerontherapeutics.com
Title
Cited by
Cited by
Year
Arginine methylation controls growth regulation by E2F‐1
EC Cho, S Zheng, S Munro, G Liu, SM Carr, J Moehlenbrink, YC Lu, ...
The EMBO journal 31 (7), 1785-1797, 2012
2612012
Arginine methylation-dependent reader-writer interplay governs growth control by E2F-1
S Zheng, J Moehlenbrink, YC Lu, LP Zalmas, CA Sagum, S Carr, ...
Molecular cell 52 (1), 37-51, 2013
1662013
Polycomb protein EZH2 regulates E2F1-dependent apoptosis through epigenetically modulating Bim expression
ZL Wu, SS Zheng, ZM Li, YY Qiao, MY Aau, Q Yu
Cell Death & Differentiation 17 (5), 801-810, 2010
1372010
The E2F family and the role of E2F1 in apoptosis
Z Wu, S Zheng, Q Yu
The international journal of biochemistry & cell biology 41 (12), 2389-2397, 2009
932009
E2F1 suppresses Wnt/β-catenin activity through transactivation of β-catenin interacting protein ICAT
Z Wu, S Zheng, Z Li, J Tan, Q Yu
Oncogene 30 (37), 3979-3984, 2011
372011
Inhibiting p53 acetylation reduces cancer chemotoxicity
S Zheng, XY Koh, HC Goh, SAB Rahmat, LA Hwang, DP Lane
Cancer Research 77 (16), 4342-4354, 2017
242017
Arginine methylation in the E2F1 pathway
S Zheng
University of Oxford, 2013
2013
organic solvents Menu
S Zheng, XY Koh, HC Goh, SAB Rahmat, LA Hwang, DP Lane
The system can't perform the operation now. Try again later.
Articles 1–8